But not every company had enough cash to completely retool their strategy
The dose is usually started low and gradually increased over time to minimize side effects and allow the body to adjust
[DOI] [PMC free article] [PubMed] 83.Manini AF, Kabrhel C, Thomsen TW
AI to predict drug interactions for Semaglutide therapy The AI in pharma market is on the fast track to growth, displaying a mammoth CAGR of 29.4% which has set it on course to surpass a value of $9.2 billion by 2030
While the medication does not directly cause muscle weakness through a neuromuscular mechanism, the combination of fatigue, gastrointestinal symptoms, rapid weight loss, and dietary changes associated with semaglutide therapy creates a clinical context where weakness can reasonably occur as a secondary phenomenon
We start with labs, health history, and a full metabolic assessment